Verve Therapeutics

VERV

Last Price

12/20/24, 09:30 AM
 EDT
$
5.74
(
+
11.2
%)

Margin of Safety

+
117.4
%
12.48
NASDAQ

Stock charts are coming!

Solt DB launched with awesome written research, bottom-up modeling, and Margin of Safety signals.

Interactive stock charts are the very next thing we're working on site-wide. Our stock charts will have additional data layers, such as flags for events, modeling refinements, and research notes; as well as historical modeled fair valuation.

Want to request new features? Don't like the position or look of something? Let us know -- we'll add or change it: invest@soltdb.com

Last Price

$
5.74

Margin of Safety

+
117.4
%

Est. Fair ValuE (PER share)

$
12.48

Portfolio Category

Growth (Speculative)
VERV

EST. Fair ValuE (PER share)

$
12.48

EST. Fair ValuE (MKT Cap)

$1.200 billion

Current Model Basis

Existing Pipeline and Tech Stack

Last Refinement

April 3, 2024

Portfolio Category

Growth (Speculative)

Allocation Suggestion

0% to 5%

Research Deep Dive

Last Updated:

Overview

Solt DB Invest will introduce Base Research for our coverage ecosystem over the next month to coincide with third-quarter 2023 earnings announcements. Check back soon!

Technology Platform

Pipeline

Portfolio

Opportunities & Advantages

Challenges & Risks

Development Risk 

Regulatory Risk 

Commercial Risk 

Dilution Risk 

Valuation Risk 

Geopolitical Risk 

Unique Risks 

Modeling Insights

News Flow & Timing